Preventive Effect of Boiogito on Metabolic Disorders in the TSOD Mouse, a Model of Spontaneous Obese Type II Diabetes Mellitus

Table 3

Effect of Boiogito on AUC in the oral glucose tolerance test

AUC (mg/ml/min)	Control	Boiogito (1%)	Boiogito (3%)
TSOD mice	89.2 ± 16.4	76.2 ± 16.8	75.8 ± 20.1
TSNO mice	61.5 ± 8.4*	58.3 ± 3.2	55.1 ± 8.3

Data represent the mean ± SD of 5–7 animals.
* P < .05, Significantly different from the TSOD control group.